The development of a self-management support model for non communicable disease prevention among people at risk of chronic illness: Bangkaja, Muang district, Chanthaburi province. VasuthadaC, JaiklaN, PrakongsriC, TheamngoenS. Minimally clinically important difference for the UCSD shortness of breath questionnaire, borg scale, and visual analog scale. Expert Rev Pharmacoecon Outcomes Res 2018 18:551-8. The EQ-5D-5L valuation study in Thailand. Pattanaphesaj J, Thavorncharoensap M, Ramos-Goñi JM, Tongsiri S, Ingsrisawang L, Teerawattananon Y. Journal of Health and Nursing Research 2020 35(3):13-23. The effects of a cognitive-behavioral therapy program on insomnia among elderly patients with major depressive disorder. Khamkaew Y, Soonthornchaiya R, Phanasathit M. Comparative study of Thai validation COPD symptom assessment tools: COPD assessment test (CAT), modified medical research council (mMRC) and clinical COPD questionnaire (CCQ) in Srinagarind hospital. Ratanawatkul P, Virojsakul P, Chumpangern W, So-ngern A, Boonsawat W, Reechaipichitkul W. Acute effects of hyperoxia on dyspnea in hypoxemia patients with chronic airway obstruction at rest. Clin Rehabil 2022 36:486-97.Īlvisi V, Mirkovic T, Nesme P, Guérin C, Milic-Emili J. Breathing exercises versus strength exercises through telerehabilitation in coronavirus disease 2019 patients in the acute phase: a randomized controlled trial. Rodríguez-Blanco C, Bernal-Utrera C, Anarte-Lazo E, Saavedra-Hernandez M, De-La-Barrera-Aranda E, Serrera-Figallo MA, et al. Persistent dyspnea, declined moderersistent dyspnea, declined moderate to vigor o vigorous physical activity ous physical activity, functional, functional status, and quality of life during the post-acute phase of COVID-19 infection: a pilot case control study. Available from: Īslan H, Tomczak C, Marciniuk D, Butcher S. Insomnia and sleep characteristics in post COVID-19 related fatigue. Rauwerda N, Kuut TA, Braamse AM, Csorba I, Nieuwkerk P, Van Straten A, et al. A lifestyle medicine approach to management of post-covid syndrome.2023. JAMA Intern Med 2023 183:232-41.īritish Society of lifestyle medicine.
Adherence to healthy lifestyle prior to infection and risk of post-COVID 19 condition.
Wang S, Li Y, Yue Y, Yuan C, Kang JH, Chavarro JE, et al. Rippe JM, Lifestyle medicine: the health promoting power of daily habits and practices. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Lopez-Leon S, Wegman-Ostrosky T, Perelman C, Sepulveda R, Rebolledo PA, Cuapio A, et al. Natural history of COVID-19 and therapeutic options. Gautret P, Million M, Jarrot PA, Camoin-Jau L, Colson P, Fenollar F, et al. Moreover, it is important to develop skilled human resources regarding lifestyle medicine. This care model should be extended to other hospitals however, treatment duration should be designed based on the clinical symptoms of each patient. A better quality of life (EQ-5D-5L score) was observed.ĬONCLUSIONS: Implementing a care model for patients with residual symptoms after COVID-19 infection, by providing behavioral modification based on lifestyle medicine in conjunction with integrative treatment, might improve patients' clinical outcomes, sleep, and quality of life. RESULTS: At the end of therapy, the severity of fatigue (Visual Analogue Fatigue Scale) and dyspnea (mMRC) decreased significantly from 5.50 (5.00-6.50) to 1.00 (0.00-1.00) ( p<0.001) and from 2.8☐.4 to 0.8☐.4 ( p<0.001), respectively. All patients received an individualized lifestyle modification program to suit their body element (Chao Roen) and integrative medicine once a week for 4 weeks. The patients’ primary symptoms included fatigue and/or dyspnea after recovering from COVID-19 with mMRC (Modified Medical Research Council) Dyspnea Scale≥2. METHODS: One group pretest–posttest research was conducted among 20 volunteers aged 20-60 with a history of COVID-19 infection. OBJECTIVES: To assess the outcomes of a care model for patients with persistent symptoms of COVID-19 infection when treated with lifestyle medicine and integrative medicine The residual symptoms of COVID-19 infection are chronic conditions that affect patients' quality of life in the short and long term.
BACKGROUND: Lifestyle medicine has been recognized as a cost-effective treatment for managing chronic illnesses.
0 kommentar(er)
